Published:28/05/2020
Repurposing or repositioning a drug is often a faster and more affordable way to develop new products than de novo drug discovery and development.
At Vectura, inhalation is our focus, and with more than 20 years’ experience, we help customers succeed in bringing inhaled medicines to market.
In a new podcast, Geraldine Venthoye, our EVP Product Development, talks about identifying the best opportunities to repurpose or reposition existing drugs for inhaled administration.
You can also read more from Geraldine on this subject in the latest issue of The Medicine Maker here.
Get in touch
If you’d like to talk to us about your project, challenge, or area of interest, we look forward to hearing from you. Click here to arrange a virtual meeting or call with one of our experts.